RBFOX3 and Alzheimer disease: At 2 months of maturation, western blot analysis confirmed that the developmental stage of control and AD organoids was different with higher expression of differentiation markers (MAP2, β3 tubulin, DCX, neurofilament (NF), NeuN) in control organoids compared with AD ones.